Pfizer Projects Over $50bn Vaccine, Therapeutic Sale In 2022
Pfizer forecast more than $50 billion in 2022 sales for its Covid-19 vaccine and therapeutic on Tuesday as the pharmaceutical giant reported a more than doubling of annual profits on strong sales of its innoculation....
English